Weird to say it about a nearly $150B company, but this could've been something of a game changer. Certainly a resounding success would've taken this upward 20% in the short term with huge cash streams to come. I get that it wasn't included in company forecasts, but it doesn't alter the fact that this does harm the medium term growth of the business given a lot of success is naturally priced into CSL.
Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-22
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$278.20 |
Change
-3.760(1.33%) |
Mkt cap ! $134.8B | |||
| Open | High | Low | Value | Volume |
| $279.50 | $280.30 | $278.20 | $220.7M | 791.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 12008 | $278.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $278.31 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.07 |
Change
-3.760 ( 0.97 %) |
||||
| Open | High | Low | Volume | ||
| $279.78 | $280.29 | $279.03 | 107046 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| CSL (ASX) Chart |